BA · Boeing Co
$193.56
+1.28 (+0.67%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$148.34B
Shares
790.37M
Volume · Oct 2
12.64M
Avg daily vol (3M)
6.46M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$193.56
Open$193.87
Day$190.27–196.93
52W close$179.12–252.15
Avg vol 30d7.5M
Short int14.2M · 1.8% float · 3.0d
Short vol51%
Last earningsOct 27, 2026
DataJan 2020–Oct 2026
Filing10-Q · Jul 28
Up next
Next earnings call
Oct 27, 2026
Scheduled
· in 3 wks
filed Jul 28, 2026
call held Jul 28, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-11.0%
Trailing year
Short interest
1.8%
Latest settlement · 3.0 days to cover
AI Brief
Q2 FY26 earnings call · Jul 28, 2026
Q2 FY26
TL;DR. Boeing posted Q2 revenue of $24.6B (up 8%), 171 commercial deliveries (highest since 2018), free cash flow of $631M, and reiterated its full-year FCF outlook of $1–$3B, while booking a $280M VC-25B charge that pushed BDS margins negative.
Bullish
- + Revenue rose 8% to $24.6B with 171 commercial deliveries, the highest quarterly total since 2018
- + Total backlog grew to a record $715B, including over 6,200 commercial airplanes valued at a record $597B
- + Free cash flow was positive $631M, better than prior guidance expectations, with full-year $1–$3B FCF outlook reiterated and Q3 expected positive in low hundreds of millions
- + 737-7 and 737-10 certification flight testing has been completed, with certification and first deliveries expected in 2027
- + 737 production ramping to 47/month with North Line low-rate production activated for the next rate break to 52/month
- + 777-9 remains on track for 2027 first delivery with 55%+ certification flight testing complete and TIA-4B FAA approval secured
Bearish
- − BDS posted a $280M VC-25B charge, driving segment operating margin to (0.2)% in the quarter
- − 787 seat certification issues continue, creating delivery lumpiness through the balance of the year
- − Commercial Airplanes operating margin remained negative at (2.7)% despite higher deliveries
- − A planned $700M DOJ payment in Q3 will weigh on near-term free cash flow
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Research
our published analysis of this company-
Research ThesisSpaceX's $1.8T cap is a two-customer AI bet, with $14.1B in CSAs carrying the entire $100B ARR claim
A Q2-print read on SpaceX as a public company: how $15.8B of the $18.4B Q2 capex flowed into the AI segment, why Customer B at 19.5% and Customer A at 18.3% of revenue sit between the $47.5B backlog and the $100B December ARR target, and how the Cursor close reframes the same concentration risk.
-
Research ThesisRocket Lab: Backlog is converting, but the $39B market cap is paying for a Neutron debut the company has yet to validate
Rocket Lab enters Q2 2026 with record backlog of $2,219.8M and guided revenue of $225.0M–$240.0M, yet the stock trades at -55.2% from its $150.23 high on a $39.0B market cap against $679.6M of trailing revenue — a gap the equity-funded growth model and the un-flown Neutron debut have to close.
Mentioned in fund letters
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Moderate
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−12%
below
Price vs 50-day avg
−9%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
20%
mid-range
Momentum
relative strength
1-month return
−8%
trailing
6-month return
−13%
trailing
YTD return
−11%
this year
Relative strength
−25%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $212 › 200d $221 — 200d above 50d
Institutional flow
Accumulating
16 of 2,648 funds reported for Sep 30 · net +1.7K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.80% of float · ▼ -10.7% MoM · 3.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
2,648 holders — near 3-yr high, broad support
Squeeze score
37
low risk · 0–100
Fundamentals
Revenue growth
+34%
Y/Y
Gross margin
5%
expanding
EPS growth
+114%
Y/Y
Free cash flow
$-1.9B
Valuation
P/E 67.5
rich
Buyback
$20.0B
authorized
Balance sheet
$43.2B
net debt
Quant / Vol
risk profile
Volatility
34%
annualized · 1-yr
Max drawdown
−27%
past year
ATR
3.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2026
BDS margin
· for the year
3.5%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−12%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
20%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $212 › 200d $221 — 200d above 50d
Institutional flow
Accumulating
16 of 2,648 funds reported for Sep 30 · net +1.7K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.80% of float · ▼ -10.7% MoM · 3.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
2,648 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $179
Now $194 · 20%
Range high $252
vs 200-day avg -12%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| 767 deliveries | 10 | the second quarter of 2026 filing | — |
| 787 deliveries | 25 | the second quarter of 2026 filing | — |
| BCA operating margins | -2.7% | the three months ended June 30, 2026 filing | — |
| Commercial airplane deliveries (Total) | 171 | the second quarter of 2026 filing | — |
| Core loss per share non-GAAP | -$0.76 | Three months ended June 30, 2026 filing | — |
| Core operating earnings/(loss) non-GAAP | $1M | Three months ended June 30, 2026 filing | — |
| Core operating margins non-GAAP | 0% | Three months ended June 30, 2026 filing | — |
| Cost of sales as a % of Revenues | 90.2% | the three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Aerospace & Defense — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BA
this stock
Boeing Co
|
$148.34B | -10.9% | +34.5% | 67.5 | 1.8% |
|
SPCX
Space Exploration Technologies Corp
|
$1.96T | — | — | — | 1.2% |
|
GE
General Electric Co
|
$339.38B | +0.5% | +18.5% | 38.5 | 1.5% |
|
RTX
RTX Corp
|
$255.27B | +0.7% | +17.1% | 33.4 | 1.0% |
|
EADSF
Airbus SE/ADR
|
$166.47B | -7.9% | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BA | -2.3% | -8.1% | -12.9% | +4.0% | -10.9% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -2.1% | -7.6% | -25.1% | +3.1% | -23.7% |
Capital returns
Buyback program
· as of Dec 17, 2018
Authorized
$20.00B
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.